HomeCompareRHHBF vs KMB

RHHBF vs KMB: Dividend Comparison 2026

RHHBF yields 2.28% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $17.2K in total portfolio value
10 years
RHHBF
RHHBF
● Live price
2.28%
Share price
$410.32
Annual div
$9.37
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.7K
Annual income
$1,518.26
Full RHHBF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — RHHBF vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHHBFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHHBF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHHBF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHHBF
Annual income on $10K today (after 15% tax)
$194.20/yr
After 10yr DRIP, annual income (after tax)
$1,290.52/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, KMB beats the other by $3,139.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHHBF + KMB for your $10,000?

RHHBF: 50%KMB: 50%
100% KMB50/50100% RHHBF
Portfolio after 10yr
$37.3K
Annual income
$3,364.79/yr
Blended yield
9.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

RHHBF
Analyst Ratings
3
Buy
5
Hold
1
Sell
Consensus: Hold
Altman Z
5.3
Piotroski
6/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHHBF buys
0
KMB buys
0
No recent congressional trades found for RHHBF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHHBFKMB
Forward yield2.28%5.25%
Annual dividend / share$9.37$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17%17%
Portfolio after 10y$28.7K$45.9K
Annual income after 10y$1,518.26$5,211.33
Total dividends collected$7.3K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold

Year-by-year: RHHBF vs KMB ($10,000, DRIP)

YearRHHBF PortfolioRHHBF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$10,967$267.32$11,314$613.68$347.00KMB
2$12,056$320.57$12,865$759.19$809.00KMB
3$13,285$385.32$14,709$943.96$1.4KKMB
4$14,679$464.29$16,919$1,180.17$2.2KKMB
5$16,268$560.96$19,588$1,484.33$3.3KKMB
6$18,086$679.77$22,838$1,879.06$4.8KKMB
7$20,178$826.39$26,832$2,395.60$6.7KKMB
8$22,599$1,008.16$31,788$3,077.63$9.2KKMB
9$25,416$1,234.62$38,000$3,986.82$12.6KKMB
10$28,713$1,518.26$45,872$5,211.33$17.2KKMB

RHHBF vs KMB: Complete Analysis 2026

RHHBFStock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Full RHHBF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this RHHBF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHHBF vs SCHDRHHBF vs JEPIRHHBF vs ORHHBF vs KORHHBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.